The group company held the 2018 annual board of directors and the board of supervisors to review and approve the annual work report and other related proposals
Release time:
2020-07-22
Group Company Convenes 2018 Board of Directors and Board of Supervisors
to Review and Approve Annual Work Report and Other Related Proposals
News 4 26 , Chairman of the Group Company Jiang Xiaomeng presided over the 10 Meeting of the 10th Board of Directors of the Company, deliberated and approved 22 related reports and proposals such as 2018 annual board of directors report and 2018 annual general manager business report.
General Manager's report pointed out that 2018 is the 31st anniversary of Peak Start-up 60#. According to the five-year development plan and annual business plan, the company has carried out various operation and management work in an orderly manner around the general policy of "determination to reform, deepen management, and promote all-round high-quality development of the enterprise " , the business plan formulated by the board of directors at the beginning of the year was well completed. The company realized operating income of 33.62 .7 billion yuan for the whole year, up 18.95% year on year, net profit attributable to shareholders 58,850.21 yuan, earnings per share reached 1.71 yuan, up 68.87% year on year, reaching a new record high. At the end of the year, total assets 49.01 .7 billion yuan, up 17.38% year on year; net assets attributable to shareholders were 31.63 .1 billion yuan, up 20.38% year on year.
With the deepening of the country's supply-side structural reform, the effect of cement de-capacity has been highlighted, 2018 The supply and demand relationship in most parts of the country has been better improved, and the overall profitability of the industry has been greatly improved. The company's cement subsidiaries adhere to the "cost leadership " strategy, through continuous optimization of organizational structure, strengthen technological transformation, effectively control production costs, improve labor productivity. Daye Jianfeng has continuously strengthened the construction of quality management system, strengthened the advanced nature of process technology, and completed a number of technical improvement projects, such as kiln tail preheater technical transformation, raw material mill technical transformation, kiln tail desulfurization technical transformation, and achieved good results. After scientific arrangement and implementation of the plan, sales volume and price have been improved. Yunnan Jianfeng firmly grasped the key projects and Jinghong market, and won the optimization of key projects with high-quality service and good reputation. While the sales volume increased, it ensured that the price continued to run at a high level. At the end of 2018 , the company made a decision to acquire all the shares of Guizhou huangpinggu longmingchuan cement co., ltd. and will continue to promote the construction of its off-site technological transformation project (with waste heat power generation) of its new dry cement production line with a daily output of 4500 tons of clinker, further expanding the company's main business scale and enhancing its core competitiveness. In
2018 , the growth rate of the pharmaceutical industry slowed down due to policies such as medical insurance fee control, bidding and price reduction, and 4+7 urban drug procurement. However, with the improvement of the aging degree of society and the enhancement of people's awareness of health care, the pharmaceutical market demand is strong. 2018 , Jianfeng Pharmaceutical carried out extensive investigation and project negotiation around the company's strategic planning, and achieved certain results. Jianfeng Pharmaceutical completed the holding and capital increase of Shanghai North Card, and acquired Anhui Zhongwang through Shanghai North Card, laying the foundation for Jianfeng Pharmaceutical to build a bulk drug manufacturing base and further improving the company's pharmaceutical business industry chain; the annual output of 20 .8 billion solid preparation project (international project) in Jinxi production base of Jianfeng pharmaceutical industry has been officially launched, and the planning and design, equipment selection, product screening and other work are progressing in an orderly manner. The establishment of Anhui Jianfeng Beika Pharmaceutical Small Molecule Targeted Drug Research Institute will further improve the company's research level of antineoplastic drugs. During the reporting period, the company increased its investment in drug research and development, and the clinical trials of Jianfeng Pharmaceutical's new anti-tumor drug DPT progressed steadily. The preclinical research of Jianfeng Yien antitumor drug JFAN-1001 is progressing smoothly. At present, preclinical toxicological, pharmacodynamic and pharmacokinetic studies have been fully carried out, and patent applications in the United States, Canada, Japan, Europe, Australia and China have been successfully completed. Jianfeng Pharmaceutical also has a number of new drugs in various stages of research and development. It has completed the pharmaceutical research of imatinib mesylate tablets and obtained BE filing. Completed the pharmaceutical research of desvenlafaxine succinate sustained-release tablets and passed the ethical review. New progress has been made in the work of "consistency evaluation " . The process, quality research and bioequivalence test of paroxetine hydrochloride tablets have been completed and reported to the National Drug Examination Center. In addition, in the face of "two-vote system " , "4+7 city drug volume procurement " and other policies brought about by market changes, the company actively formulate differentiated sales policies, integrate regional resources, and make useful attempts for marketing transformation.
2018 , the company's other business sectors also better achieved their business objectives, peak health continued to promote the common development of terminals and e-commerce, through the network platform, exhibitions, media and other ways to carry out investment, according to market changes to improve the marketing model. Jianfeng International Trade has completed the construction of the new warehouse (e-commerce logistics park) project, and introduced Aneng Logistics and Zhongtong Express into the park for operation. Peak Cable actively develop new customers, expand the OEM business, operating income has achieved a greater growth. On the day of
, the company also held the 107 meeting of 6 of the 9th board of supervisors, deliberated and approved the company's 2018 annual board of supervisors work report, 2018 annual financial final accounts report and other 9 related reports and proposals. (Yu Fruit)
More information
Teachers and Students of Zhejiang Gongshang University Visit Peak Health
News from our newspaper On the morning of June 9, a group of 18 teachers and students from Zhejiang Gongshang University came to Jianfeng Health for a visit and discussion, and conducted research on the establishment of Zhejiang Gongshang University Food Industrialization Research Institute in Jinhua. The leader of this visit is Professor Song Guanglei from the School of Food and Biological Engineering, Zhejiang Gongshang University. The teachers and students are mainly from the School of Food and Engineering, specializing in food science, food safety, biochemical and biotechnology, focusing on extraction and separation, functional activity and The research of functional food, in addition to the professor of the Department of E-commerce of the School of Management Engineering and E-commerce. Chen Daiyou, general manager of Jianfeng Health, Li Wende, deputy general manager, and relevant personnel from R & D, quality management, administrative personnel and other departments attended the forum. Li Wende introduced the basic situation, technical production level, scientific and technological research and development characteristics of Jianfeng Health Company in the form of PPT, as well as the relevant policies of Jinhua Municipal Government on talent introduction. Chen Daiyou focused on the development vision of Jianfeng Health Technology and the construction of scientific and technological talents, and welcomed graduate students from the Industrial and Commercial University to join the team of Jianfeng Health after graduation. Professor Song Guanglei fully affirmed the software and hardware facilities and humanistic management of Jianfeng Health Company. He said that most of the teachers and students who came to visit this time were professional in line with the industry of Jianfeng Health Company. The two sides could carry out in-depth cooperation in product development, technology upgrading and talent reserve. Fourteen graduate students also introduced their respective situations and study and research directions. After the symposium, the teachers and students visited the health company's testing center, R & D laboratory and plant extraction workshop with great interest.
2020
07-31
Trial operation of large pharmacy micro-mall
The construction of the micro-mall of Jianfeng Pharmacy is basically ready at present. On June 17, Shuangxi and Donglai chain stores took the lead in the trial operation of the micro-mall. At present, online consumption through computers and mobile phones has become a way of life in China. In particular, various software represented by WeChat covers more than 90% of smart phones, and has many functions such as information exchange and online payment. It is a new type of shopping system based on WeChat platform, using mobile Internet technology to realize the integration of online and offline marketing. At present, there are more than 1000 kinds of commodities on the shelves of the micro-mall of Jianfeng pharmacy, mainly OTC commodities of over-the-counter drugs, which are basically synchronized with pharmacies. Customers only need to pay attention to the public number of Jianfeng Pharmacy and enter the micro-mall to collect coupons through the "online drug purchase" on the public number page. They can find the required drugs on the mobile phone to purchase and pay for them. The delivery method can be delivered to the door or the store can pick them up by itself. The purchase of drugs through the micro-mall is not only convenient and fast, but also can reduce the phenomenon of queuing in the store. According to reports, the opening of the micro mall by the big pharmacy is to expand the new service model and provide more and better extended services to the masses. Prior to this, the WeChat public number of the large pharmacy has already made a useful attempt to push health information, and the operation of the micro-mall will further provide users with new channels for seeking medical advice. While further improving the micro-mall system, the large pharmacy will add "online pharmacists" and other service items to provide users with real-time consulting services such as medication guidance, drug purchase recommendation, health care knowledge and so on in the form of voice or text. (Tang Wenshu)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-30
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
On May 27, the Party Committee of the Group Company held a branch secretary meeting to comprehensively review and summarize the Party building work of the Company in 2016 and sign the responsibility book for the management of Party building work objectives in 2017. At the meeting, Qin xuping, member of the party Committee of the group company and director of the party-mass work department, made a comprehensive summary of the company's party building work in 2016, put forward the 2017 work plan, and conveyed the "key points of party building work in the city's two new organizations in 2017" issued by the two new working committees of Jinhua municipal party Committee, and the spirit of the speech made by the relevant leaders of the municipal party Committee at the recent meeting of the city's two new working committee, this paper explains the "ten questions" of the two new grass-roots party organizations, the "ten questions" of Party members and some problems that need attention in the process of Party member development. Members of the party committee of the group company, secretaries of grass-roots party committees and branch secretaries expressed their views and conducted extensive exchanges on such topics as how to deepen the "two learning and one doing", further play the role of party organizations in the process of enterprise operation and management, and how to do a good job in organizational construction in 2017. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, on behalf of the party committee of the group, signed the 2017 party building work target management responsibility letter with the heads of the party organizations of various professional companies and directly affiliated enterprises. In his speech at the meeting, Jiang Xiaomeng said that the Politburo meeting of the CPC Central Committee held on the 26th reviewed and approved the "Decision on Amending the Regulations on the Inspection Work of the Communist Party of China" and other reports, which is a major measure to further implement the provisions of the party constitution and strengthen internal party supervision. Specific to the internal party building work of the enterprise, all cadres and party members should earnestly study relevant policies and documents, and earnestly understand the spirit of the central government
2020
07-31